Literature DB >> 12386337

Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Jiyan Ma1, Robert Wollmann, Susan Lindquist.   

Abstract

Changes in prion protein (PrP) folding are associated with fatal neurodegenerative disorders, but the neurotoxic species is unknown. Like other proteins that traffic through the endoplasmic reticulum, misfolded PrP is retrograde transported to the cytosol for degradation by proteasomes. Accumulation of even small amounts of cytosolic PrP was strongly neurotoxic in cultured cells and transgenic mice. Mice developed normally but acquired severe ataxia, with cerebellar degeneration and gliosis. This establishes a mechanism for converting wild-type PrP to a highly neurotoxic species that is distinct from the self-propagating PrP(Sc) isoform and suggests a potential common framework for seemingly diverse PrP neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386337     DOI: 10.1126/science.1073725

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  131 in total

1.  The CAG repeat in SCA12 functions as a cis element to up-regulate PPP2R2B expression.

Authors:  Chih-Hsin Lin; Chiung-Mei Chen; Yi-Ting Hou; Yih-Ru Wu; Hsiu-Mei Hsieh-Li; Ming-Tsan Su; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2010-06-09       Impact factor: 4.132

Review 2.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment.

Authors:  Carlos J Bosques; Barbara Imperiali
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

4.  Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.

Authors:  Erwann Rousseau; Benjamin Dehay; Léa Ben-Haïem; Yvon Trottier; Michel Morange; Anne Bertolotti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 5.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

Review 6.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

7.  Direct observation of multiple misfolding pathways in a single prion protein molecule.

Authors:  Hao Yu; Xia Liu; Krishna Neupane; Amar Nath Gupta; Angela M Brigley; Allison Solanki; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly' intracellular aggregates.

Authors:  Yaping Gu; Susamma Verghese; Sharmila Bose; Maradumane Mohan; Neena Singh
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.